Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Milton S. Hershey Medical Center. Penn State Health, Penn State College of Medicine, Hershey, PA, USA.
J Diabetes Sci Technol. 2022 May;16(3):771-774. doi: 10.1177/1932296820982661. Epub 2021 Jan 7.
The increasing prevalence of diabetes permeates hospitals and dysglycemia is associated with poor clinical and economic outcomes. Despite endorsed guidelines, barriers to optimal management and gaps in care prevail. Providers' limitations on knowledge, attitudes, and decision-making about hospital diabetes management are common. This adds to the complexity of dispersed glucose and insulin dosing data within medical records. This creates a dichotomy as safe and effective care are key objectives of healthcare organizations. This perspective highlights evidence of the benefits of clinical decision support (CDS) in hospital glycemic management. It elaborates on barriers CDS can help resolve, and factors driving its success. CDS represents a resource to individualize care and improve outcomes. It can help overcome a multifactorial problem impacting patients' lives on a daily basis.
糖尿病的患病率不断上升，弥漫在医院各个角落，血糖异常与较差的临床和经济结局相关。尽管有已认可的指南，但仍存在着阻碍最佳管理和护理缺口的问题。医护人员在知识、态度和医院糖尿病管理决策方面存在局限性是很常见的。这增加了医疗记录中葡萄糖和胰岛素剂量数据分散的复杂性。这形成了一个二分法，因为安全有效的护理是医疗保健组织的关键目标。这一观点强调了临床决策支持（CDS）在医院血糖管理中带来的益处的证据。它详细说明了 CDS 可以帮助解决的障碍，以及推动其成功的因素。CDS 代表了一种资源，可以实现个体化护理和改善结局。它可以帮助克服一个影响患者日常生活的多因素问题。
